Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726268 · ClinicalTrials.gov registry record · Phase 4
Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 907
- Enrollment target
NCT03726268 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 907 participants.
The verdict
NCT03726268, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 907 participants
- Enrollment target
Study Summary
The overall goal of this research is to improve perioperative pain treatment, decrease post-operative opioid consumption, diminish opioid related side effects, and reduce postop opioid prescribing (and hence opportunity for diversion, abuse, addiction, and fatal overdose).
Interventions
- DRUG Methadone
- DRUG Hydromorphone
- DRUG Morphine
- DRUG Fentanyl
- DRUG Sufentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 907 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2024-01-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03726268
The ClinicalTrials.gov registry entry for NCT03726268 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 907 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Methadone is the first listed.
NCT03726268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03726268 about?
NCT03726268 is a clinical study titled "Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)". The overall goal of this research is to improve perioperative pain treatment, decrease post-operative opioid consumption, diminish opioid related side effects, and reduce postop opioid prescribing (and hence opportunity for diversion, abuse, addiction, and fatal overdose).
What is the current status of trial NCT03726268?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 907 participants. The study started on 2018-11-29. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT03726268?
The interventions under investigation include: Methadone (DRUG), Hydromorphone (DRUG), Morphine (DRUG), Fentanyl (DRUG), Sufentanil (DRUG).
Who is sponsoring clinical trial NCT03726268?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.